CDC panel OKs recommending Pfizer COVID-19 booster for kids 5 to 11
U.S. health advisers are urging a booster dose of Pfizer's COVID-19 vaccine for kids ages 5 to 11.
Stay updated with breaking news from Use Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. health advisers are urging a booster dose of Pfizer's COVID-19 vaccine for kids ages 5 to 11.
The U.S. Food and Drug Administration (FDA) has given approval for the commercialization of Eli Lilly and Company and Incyte’s Olumiant (baricitinib), setting a precedent for COVID-19 treatments.
The vaccine maker faces a few big uncertainties.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Q1 2022 total revenue was $8.7 million, including product sales of $7.9 million. Core non-COVID-19 product sales were an estimated $7.6 million, ...